Quick Answer
GLOBUS MEDICAL INC reported Stockholders Equity of $4.57 billion for the year ending 2025.
- GLOBUS MEDICAL INC showed an increase of +9.5% in Stockholders Equity from 2024 to 2025.
- This data is from GLOBUS MEDICAL INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2018 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $868.89 million | Q2 2017: $905.30 million | Q3 2017: $935.26 million | Q1 2022: $1.79 billion | Q2 2022: $1.70 billion | Q3 2022: $1.76 billion | Q1 2023: $1.91 billion | Q2 2023: $1.99 billion | Q3 2023: $4.19 billion | Q1 2024: $3.92 billion | Q2 2024: $3.98 billion | Q3 2024: $4.07 billion | Q1 2025: $4.09 billion | Q2 2025: $4.30 billion | Q3 2025: $4.40 billion.
- Over the full 20 years of available data (2018 to 2025), GLOBUS MEDICAL INC's Stockholders Equity has grown by 285.8%.
- Historical annual values: Fiscal year 2025: $4.57 billion | Fiscal year 2024: $4.18 billion | Fiscal year 2023: $4.00 billion | Fiscal year 2022: $1.85 billion | Fiscal year 2022: $1.76 billion | Fiscal year 2022: $1.70 billion | Fiscal year 2022: $1.79 billion | Fiscal year 2021: $1.74 billion | Fiscal year 2021: $1.72 billion | Fiscal year 2021: $1.64 billion | Fiscal year 2021: $1.56 billion | Fiscal year 2020: $1.51 billion | Fiscal year 2020: $1.42 billion | Fiscal year 2020: $1.34 billion | Fiscal year 2020: $1.36 billion | Fiscal year 2019: $1.40 billion | Fiscal year 2019: $1.34 billion | Fiscal year 2019: $1.29 billion | Fiscal year 2019: $1.24 billion | Fiscal year 2018: $1.19 billion.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: